Cardiac Imaging

What Is the Best Initial Imaging for Chronic Chest Pain in Known, Untreated Coronary Disease?

·
What Is the Best Initial Imaging for Chronic Chest Pain in Known, Untreated Coronary Disease?

A 68-year-old male with a history of a non-ST-elevation myocardial infarction two years ago, managed medically, presents to your clinic with two months of intermittent, exertional chest pressure. He has not undergone percutaneous coronary intervention or bypass grafting. His symptoms are stable, but you have a high pre-test probability for significant coronary artery disease (CAD), and the clinical question is clear: is his known disease now causing hemodynamically significant ischemia that warrants more aggressive treatment? This scenario—initial imaging for chronic chest pain in a patient with known, but untreated, ischemic heart disease—requires a careful choice of diagnostic study. According to the American College of Radiology (ACR) Appropriateness Criteria, a transthoracic stress echocardiogram is Usually Appropriate and often the most effective first step.

Who Fits This Clinical Scenario?

This guidance applies to a specific and common patient population: individuals with chronic, stable chest pain who have a high probability of coronary artery disease because it has already been established. The key inclusion criteria are:

  • Chronic Chest Pain: The symptoms are stable and have been present for weeks or months, often with a predictable, exertional pattern. This is not an acute coronary syndrome workup.
  • High Probability of CAD: The patient has a documented history of ischemic heart disease. This could be from a prior myocardial infarction, a previous abnormal stress test, or a prior angiogram (invasive or CT) that showed atherosclerotic plaque.
  • No Prior Definitive Treatment: This is a critical distinction. The patient has not had coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) with stenting. They are on medical management alone.

This workflow is distinct from that for a patient with a similar high-risk profile but no established diagnosis. For instance, a patient with multiple risk factors (diabetes, hypertension, hyperlipidemia) but no prior cardiac events or imaging falls under the sibling scenario, “Chronic chest pain; high probability of coronary artery disease. No known ischemic heart disease,” which carries its own set of imaging considerations. This article is exclusively for the patient in whom the presence of atherosclerosis is already a given.

What Diagnoses Are You Working Up in This Scenario?

In this context, the imaging goal is not to discover the presence of coronary disease—that is already known. Instead, the primary objective is functional assessment and risk stratification. The key questions you are trying to answer with imaging center on the physiological impact of the known anatomical disease.

Inducible Myocardial Ischemia: This is the central diagnosis being investigated. You need to determine if one or more of the known coronary plaques has become flow-limiting enough to cause a supply-demand mismatch in the myocardium during stress. A positive finding confirms that the patient’s symptoms are likely due to significant stenosis and places them at higher risk for future cardiac events.

Extent and Severity of Ischemic Burden: Beyond a simple positive or negative result, the imaging study aims to quantify the ischemia. Is it a small, single-territory defect or a large, multi-vessel territory of myocardium at risk? This information is crucial for guiding downstream decisions, particularly whether to pursue revascularization over continued medical therapy.

Assessment of Left Ventricular Function: Any cardiac imaging study in this population should also evaluate baseline left ventricular (LV) systolic function. A reduced ejection fraction is a powerful negative prognostic indicator. The study can also identify regional wall motion abnormalities at rest, suggesting prior infarction.

Evaluation for Other Cardiac Etiologies: While less likely, the study can help rule out other cardiac causes of chest pain that may coexist with CAD, such as significant valvular heart disease (e.g., aortic stenosis) or hypertrophic cardiomyopathy, which can also present with exertional chest pain.

Why Is Transthoracic Stress Echocardiography the Recommended Study for This Presentation?

For a patient with known but untreated CAD, the clinical question shifts from “Is there plaque?” to “Is the plaque causing a problem?” A transthoracic stress echocardiogram directly answers this by assessing the functional consequence of coronary stenoses. The ACR rates this study as Usually Appropriate for this scenario because it provides a robust, radiation-free method to detect inducible ischemia.

The test involves acquiring transthoracic echocardiogram images at rest and then immediately after peak stress, which can be induced either through exercise (treadmill or bicycle) or pharmacologically (typically with dobutamine). The interpreting physician compares the regional wall motion of the left ventricle between the rest and stress images. A new or worsening wall motion abnormality with stress is a specific marker for ischemia in the corresponding coronary artery territory. This modality is widely available, relatively inexpensive, and provides crucial information on LV function and valvular integrity simultaneously.

Several other advanced imaging tests are also rated Usually Appropriate, but stress echo often represents the best initial choice due to its balance of diagnostic accuracy, safety, and accessibility. Let’s compare it to two alternatives:

  • Coronary CT Angiography (CTA): While also rated Usually Appropriate, CTA is an anatomical test. It excels at visualizing coronary plaque and stenosis. However, in a patient with known disease, CTA may simply re-demonstrate the known plaque without clarifying its hemodynamic significance. It also involves both iodinated contrast and ionizing radiation (☢☢☢ 1-10 mSv). It is most useful when the anatomical details of the known disease are unclear or when a non-invasive anatomical roadmap is needed before a potential intervention.
  • CT Coronary Calcium Score: This study is rated Usually Not Appropriate. A calcium score quantifies the total burden of calcified plaque but provides no information about luminal stenosis or functional ischemia. Since CAD is already established in this patient, confirming the presence of calcium adds no new clinical information and fails to answer the primary question about ischemia. Ordering this test is a common pitfall and represents a misapplication of a screening tool to a diagnostic problem.

Ultimately, stress echocardiography’s ability to provide a direct physiological assessment of ischemia without radiation exposure makes it an excellent first-line imaging choice in this specific clinical setting.

What’s Next After Transthoracic Stress Echocardiography? Downstream Workflow

The results of the stress echocardiogram will directly guide your next management steps. The decision tree is relatively straightforward and aimed at appropriate risk stratification and treatment.

If the study is positive for ischemia: A finding of a new, reversible regional wall motion abnormality indicates hemodynamically significant coronary stenosis. The next step is typically a referral to cardiology for consideration of invasive coronary angiography (ICA). The ICA will confirm the anatomy, assess the severity of the stenosis, and allow for potential percutaneous coronary intervention (PCI) with stenting during the same procedure. The extent and location of ischemia seen on the stress echo help inform the urgency and planning for the invasive procedure.

If the study is negative for ischemia: A normal stress echocardiogram, where the patient achieves an adequate level of stress and has good quality images, is highly reassuring. It suggests that the known coronary lesions are not flow-limiting and that the patient is at low risk for a major adverse cardiac event in the near term. The appropriate next step is to continue and optimize guideline-directed medical therapy for stable ischemic heart disease. The patient’s chest pain may be attributable to non-ischemic causes or microvascular dysfunction.

If the study is indeterminate or technically limited: In some cases, such as in patients with obesity or lung disease, the acoustic windows for the echocardiogram may be poor, rendering the study non-diagnostic. In other cases, the patient may be unable to reach their target heart rate. When a stress echo is inconclusive, the next step is to pursue an alternative non-invasive functional study. Both stress cardiac MRI and nuclear myocardial perfusion imaging (SPECT or PET) are rated Usually Appropriate and are excellent alternatives for assessing ischemia.

Pitfalls to Avoid (and When to Get Help)

Navigating this scenario requires avoiding a few common diagnostic errors. First, do not order a test focused solely on anatomy, like a coronary calcium score, when the clinical question is about function. Second, be precise about the patient’s history; this guidance is for patients without prior revascularization. A patient with a prior stent or bypass graft presenting with new chest pain requires a different workup focused on in-stent restenosis or graft failure. Third, ensure the patient is a suitable candidate for a stress test; those with contraindications like severe, symptomatic aortic stenosis or unstable angina need a different approach. If the non-invasive functional test is positive or if the patient’s symptoms accelerate despite medical therapy, prompt referral to a cardiologist for consideration of invasive angiography is warranted.

Related ACR Topics and Tools

This article covers one specific variant within a broader topic. For a comprehensive overview of imaging choices across different patient presentations, please consult the parent guide. The following GigHz tools can also support your clinical decision-making:

Frequently Asked Questions

Why not go straight to invasive coronary angiography (cardiac cath) since the patient has known disease?

While invasive coronary angiography (ICA) is the gold standard for defining coronary anatomy, it is an invasive procedure with inherent risks. For a patient with stable chronic chest pain, the first step is to prove that their symptoms are caused by ischemia (a functional problem). A non-invasive stress test like a stress echo can confirm this. If ischemia is demonstrated, then proceeding to an invasive procedure is justified. If no ischemia is found, the patient can often be spared the risks of an unnecessary invasive procedure.

What if my patient cannot exercise for the stress portion of the echocardiogram?

This is a common situation. If a patient cannot exercise due to arthritis, deconditioning, or other limitations, a pharmacologic stress agent can be used instead. Dobutamine is an inotrope and chronotrope that mimics the effects of exercise on the heart and is commonly used for pharmacologic stress echocardiography. Alternatively, vasodilator agents like regadenoson can be used for pharmacologic nuclear stress tests (SPECT/PET).

Is stress cardiac MRI a better option than stress echo?

Stress cardiac MRI (CMR) is also rated ‘Usually Appropriate’ and is an excellent test for ischemia, with high spatial resolution and diagnostic accuracy. It can be particularly useful in patients with poor acoustic windows for echo. However, stress CMR is less widely available, more expensive, and takes longer to perform than stress echo. It is also contraindicated in patients with certain implants or severe claustrophobia. For these reasons, stress echo is often considered the more practical initial test for many patients.

How does this workup differ from a patient with high-risk factors but no known history of heart disease?

In a patient with no known CAD, the initial imaging may serve a dual purpose: to detect ischemia and, in some cases, to establish the diagnosis of CAD by visualizing plaque (e.g., with coronary CTA). In this scenario, where CAD is already known, the focus is purely on the functional significance of that disease. Therefore, functional tests like stress echo, stress MRI, or nuclear MPI are prioritized over purely anatomical tests.

My patient had a coronary CTA a few years ago showing non-obstructive plaque. Why do they need another test now?

A prior CTA showing non-obstructive plaque establishes the diagnosis of CAD, placing the patient in this exact clinical scenario. However, coronary artery disease is a progressive process. The new or worsening chest pain suggests that one of those previously non-obstructive plaques may have progressed to become flow-limiting. The purpose of the new stress test is to determine if this functional change has occurred, which the old anatomical CTA cannot answer.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026